INNATE PHARMA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-09-17
Jeet Mukherjee
Analyst
U.S. Bancorp
Equibles does not estimate personal net worth.
About Jeet Mukherjee
Jeet Mukherjee is recorded as Analyst at U.S. Bancorp. Jeet Mukherjee has spoken on 1 earnings call across 1 company, most recently for INNATE PHARMA on September 17, 2026. The companies whose calls Jeet Mukherjee spoke on are classified in the Healthcare sector.
Jeet Mukherjee on recent calls
“So pending an accelerated approval there, could you speak to the potential for frontline off-label use for luxutimab and cesaree syndrome? given that seems to be the case with mogulizumab.”
Affiliation history
-
U.S. Bancorp
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Publication of half year financial statements
INNATE PHARMA